InvestorsHub Logo

CallMeCrazy

11/22/14 3:51 PM

#79223 RE: daydreaming2 #79222

daydreaming2, your opinion and mine!

F1ash

11/22/14 3:53 PM

#79224 RE: daydreaming2 #79222

A couple of details. If I understood the OTC rep correctly it would be $ 7,500 for CTIX to remain on the QB. Since the grace period is over now CTIX would have to pay $10,000 to return to QB status. So $10,000 would be the figure. Leo knows better than we do, I imagine. I do believe the down listing came at an inopportune time and may have affected the share price increase negatively.

edge

11/22/14 7:45 PM

#79241 RE: daydreaming2 #79222

There is only one set of opinions I value as a Cellceutix shareholder and that is Leo's and Dr Menon's. All the rest is noise which I choose to ignore.................I could care less about what anyone else thinks but that's just me, Shalom.

BooDog

11/23/14 5:06 AM

#79255 RE: daydreaming2 #79222

The only argument that makes sense to me is remaining public.

And that we are. IMO, everything else about the subject is just noise. We're on the right path and to me that's all that matters. We'll see this uplist when it's good and ready. Why waste good $$ on something that's not needed.

IMO.



daydreaming2

I think Leo's position on not wasting $20 let alone $17,500 on a different OTC level that means little to nothing is why I'm glad he is in charge! I'm not sure why some think wasting the money on another OTC position when the plan is to uplist to a bigger market is so important. I have not heard one good argument that makes good buisness sense. I guess if he was planning on milking the stock for some cash it might be a good move, but what's best for the company and LONG TERM investors is not to waste money. The true value will be represented soon enough!

Of course in my opinion!

GLTA

GlTA